French DRG (diagnosis related groups) system introduction date slips:
This article was originally published in Clinica
The October 1 deadline by which all French private healthcare general medicine and obstetrics facilities were meant to have introduced new accounting procedures has not been met. The government failed to make available in time the list of charges which would allow these facilities to introduce diagnosis-related group accounting methods whereby hospitals are paid a set sum based on the average costs of treating a given condition. It seems that the list of tariffs may not be available until December.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.